| DIRECT COMPETITOR COMPARISON | |
| IPXL | MYL | Pvt1 | TEVA | Industry | | Market Cap: | 705.36M | 5.46B | N/A | 46.51B | 128.60M | | Employees: | 768 | 15,000 | 1501 | 38,307 | 181 | | Qtrly Rev Growth (yoy): | 76.60% | -23.70% | N/A | 24.90% | 14.60% | | Revenue (ttm): | 226.97M | 4.92B | 200.00K1 | 12.95B | 31.21M | | Gross Margin (ttm): | 52.78% | 40.52% | N/A | 55.30% | 72.61% | | EBITDA (ttm): | 24.66M | 1.06B | N/A | 3.94B | -1.65M | | Oper Margins (ttm): | 6.20% | 13.54% | N/A | 24.35% | 2.37% | | Net Income (ttm): | 23.60M | 49.70M | N/A | 953.00M | N/A | | EPS (ttm): | 0.389 | 0.163 | N/A | 1.093 | N/A | | P/E (ttm): | 29.31 | 109.63 | N/A | 48.30 | 13.73 | | PEG (5 yr expected): | 0.89 | 0.66 | N/A | 0.98 | 2.18 | | P/S (ttm): | 3.11 | 1.11 | N/A | 3.59 | 3.28 |
|
| BIOTECHNOLOGY COMPANIES RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Amgen Inc. | AMGN | 56.35 | 0.00% | 57.03B | 12.29 | | Genentech, Inc. | Private - View Profile | | Biogen Idec Inc. | BIIB | 46.94 | 0.00% | 13.57B | 15.71 | | Genzyme Corp. | GENZ | 50.70 | 0.00% | 13.45B | 28.91 | | Merck Serono S.A. | Private - View Profile | | Chiron Corporation | Private - View Profile | | Gilead Sciences Inc. | GILD | 46.11 | 0.00% | 41.50B | 17.83 | | MedImmune, Inc. | Private - View Profile | | Life Technologies Corporation | LIFE | 49.78 | 0.00% | 8.88B | 1015.92 | | Teva Pharmaceutical Industries Limited | TEVA | 52.79 | 0.00% | 46.51B | 48.30 |
|
| GENERIC DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Sandoz International GmbH | Private - View Profile | | Watson Pharmaceuticals Inc. | WPI | 37.09 | 0.00% | 3.94B | 19.12 | | Barr Pharmaceuticals, Inc. | Private - View Profile | | King Pharmaceuticals Inc. | KG | 11.83 | 0.00% | 2.94B | N/A | | Ranbaxy Laboratories Limited | Private - View Profile | | Mylan, Inc. | MYL | 17.87 | 0.00% | 5.46B | 109.63 | | Pfizer Inc. | PFE | 18.17 | 0.00% | 146.62B | 15.09 | | Johnson & Johnson | JNJ | 62.84 | 0.00% | 173.38B | 13.72 | | GlaxoSmithKline plc | GSK | 41.47 | 0.00% | 105.13B | 13.17 | | Sanofi-Aventis | SNY | 37.96 | 0.00% | 99.12B | N/A |
|
| DRUGMAKERS RANKED BY SALES | |
|
| Company | Symbol | Price | Change | Market Cap | P/E | | Novartis AG | NVS | 55.60 | 0.00% | 126.28B | 16.65 | | RHHBY.PK | 40.92 | 0.00% | N/A | N/A | | AstraZeneca plc | AZN | 44.83 | 0.00% | 65.00B | 9.00 | | Abbott Laboratories | ABT | 54.49 | 0.00% | 84.28B | 14.76 | | Bristol-Myers Squibb Co. | BMY | 25.31 | 0.00% | 50.14B | 13.09 |
|
| NEWS ON DIRECT COMPETITORS | |
|
|
|